During the past decade, Mercy Hospital Springfield conducted 191 clinical trials. In the 10-year time frame, 191 clinical trials started and 174 clinical trials were completed, i.e. on average, 91.1% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 82 clinical trials were completed. i.e. 143.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital Springfield" #1 sponsor was "National Cancer Institute (NCI)" with 173 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "Alliance for Clinical Trials in Oncology" with 43 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "Gynecologic Oncology Group" with 25 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital Springfield" #1 collaborator was "National Cancer Institute (NCI)" with 183 trials as a collaborator, "NRG Oncology" with 56 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital Springfield" are "Recurrent Ovarian Carcinoma" (20 trials), "Recurrent Fallopian Tube Carcinoma" (15 trials), "Recurrent Primary Peritoneal Carcinoma" (15 trials), "Invasive Breast Carcinoma" (12 trials) and "Recurrent Breast Carcinoma" (12 trials). Many other conditions were trialed in "Mercy Hospital Springfield" in a lesser frequency.

Most popular intervention types in "Mercy Hospital Springfield" are "Drug" (291 trials), "Other" (234 trials), "Biological" (134 trials), "Procedure" (90 trials) and "Radiation" (64 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (126 trials), "Quality-of-Life Assessment" (89 trials), "Questionnaire Administration" (56 trials), "Paclitaxel" (50 trials) and "Carboplatin" (44 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital Springfield" are 270 trials for "All" genders, 98 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Hospital Springfield". undefined are not yet recruiting, 87 are recruiting, 153 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Mercy Hospital Springfield, 9 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital Springfield, 11 "Phase 1" clinical trials were conducted, 185 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".